No. |
薬物名(臨床試験情報から抽出) |
DrugBank |
KEGG DRUG * |
KEGG GENES * |
KEGG PATHWAY |
指定難病告示番号 * |
1 |
(e)-1-(4-((1r,2s,3r)-1,2,3,4-tetrahydroxybutyl)-1h-imidazol-2-yl)ethanone oxime |
- |
- |
- |
- |
1件: 161 |
2 |
Botulism toxin treatment |
- |
- |
- |
- |
1件: 161 |
3 |
Celecoxib |
Celecoxib |
D00567 |
1件: PTGS2 |
20件: Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
8件: 2, 3, 34, 46, 70, 89, 161, 271 |
4 |
Lx3305 |
- |
- |
- |
- |
2件: 46, 161 |
5 |
Lx3305 250 mg capsule |
- |
- |
- |
- |
1件: 161 |
6 |
None |
- |
- |
- |
- |
8件: 46, 78, 84, 96, 160, 161, 171, 299 |
7 |
Scenesse |
- |
- |
- |
- |
1件: 161 |